OCT461201

· Oxford Cannabinoid Technologies Holdings PLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OCT461201, covering 2024-05-03 to 2024-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Oral Dose Study to Investigate the Effects of OCT461201 in Healthy Volunteers [Phase 1]